Chinese widow, 23, vows not to remarry, triggers mixed reaction, loyalty discourse
Wu Tiexin, 36, who lived in Shuangyashan in Heilongjiang province, in northeastern China, died of heart problems caused by diabetes on July 12, according to Jimu News.
'You married me and brought me home on November 5, 2023. I sent you away to decorate our home in the next life on July 13, 2025. Do not have any illness and be healthy in your afterlife,' Wu's wife, surnamed Lu, wrote on social media in the wake of his death.
Wu was diagnosed with diabetes at the age of 10.
Loyal widow Lu said she wants her late husband to 'decorate our home in the next life'. Photo: Weibo
He was hospitalised for suffering from an acute serious heatstroke in mid-June after high temperatures hit the northeastern regions of China, including his hometown.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
9 hours ago
- South China Morning Post
New Chinese medicinal wines in Hong Kong meld traditional ingredients with modern mixology
Peek along the bottom shelves of Hong Kong supermarkets and grocery stores and you might see a category of booze once popular with both rich and poor: medicinal wines. Advertisement Yellow or rice wines infused with traditional Chinese medicine (TCM) ingredients were well loved among Hongkongers – they drank them 'for health' – until the 1980s and '90s. Some of the better-known medicinal wine labels were Shi Quan Da Bu Jiu – 'the ten complete wellness wine' – from mainland China, and Yomeishu – 'wellness wine' in Japanese – from Japan. They even had television advertisements. While these elixirs sank into obscurity in the decades that followed, bartender Dennis Mak and TCM practitioner James Ting are planning to revive the wines-for-wellness concept. Dennis Mak and James Ting's drinks brand Magnolia Lab currently offers two botanical liqueurs, Magnolia and Roselle. Photo: Magnolia Lab In 2019, the duo created Magnolia Lab, a drinks brand that combines traditional herbal and medicinal wines with modern mixology.
South China Morning Post
12 hours ago
- South China Morning Post
How Hong Kong can lead in patient-focused ethical AI healthcare
Hong Kong is uniquely positioned to lead the world in AI-based advances in healthcare. This was the view expressed by experts at the recent annual Asia Summit on Global Health. Firms like Bain and Company similarly see diverse patient populations and strong government support as key advantages in the Asia-Pacific's development as a hub for medical technology innovation. This raises big hopes and important ethical questions about AI's role in the future of healthcare. As Hong Kong strives to lead innovation in the field, will it ensure AI application is ethical and genuinely serves the interests of patients? The evolving ethics of AI in biomedicine was the topic of a recent seminar we spoke at, hosted by the Medical Ethics and Humanities Unit at the University of Hong Kong's Li Ka Shing Faculty of Medicine. The forum discussed key ethical frameworks and encouraged thoughtful public conversation on the use of AI in healthcare. Ethical reflection, discussion with stakeholders and carefully crafted guidelines are all vital to ensuring this technology is used to improve human lives. If implemented well, AI has tremendous potential for good. It may enhance patient experience, improve population health, reduce costs and increase physician well-being by reducing fatigue and making the work more meaningful. With medical imaging, for example, AI's capability in analysing images exceeds the human eye. AI algorithms based on deep learning models can detect anomalies easy for a human to miss. AI can therefore enhance doctors' ability to determine the results of tests for rectal cancer, lung disease and other illnesses. This elevates the standard of care, a clear win for patients. Similarly, where AI is used to enhance robotic-assisted surgeries , this means greater precision. If the ethics of data storage can be addressed, such applications should be relatively uncontroversial.
South China Morning Post
12 hours ago
- South China Morning Post
How Hong Kong can lead in patient-focused ethical AI healthcare
Hong Kong is uniquely positioned to lead the world in AI-based advances in healthcare. This was the view expressed by experts at the recent annual Asia Summit on Global Health. Firms like Bain and Company similarly see diverse patient populations and strong government support as key advantages in the Asia-Pacific's development as a hub for medical technology innovation. This raises big hopes and important ethical questions about AI's role in the future of healthcare. As Hong Kong strives to lead innovation in the field, will it ensure AI application is ethical and genuinely serves the interests of patients? The evolving ethics of AI in biomedicine was the topic of a recent seminar we spoke at, hosted by the Medical Ethics and Humanities Unit at the University of Hong Kong's Li Ka Shing Faculty of Medicine. The forum discussed key ethical frameworks and encouraged thoughtful public conversation on the use of AI in healthcare. Ethical reflection, discussion with stakeholders and carefully crafted guidelines are all vital to ensuring this technology is used to improve human lives. If implemented well, AI has tremendous potential for good. It may enhance patient experience, improve population health, reduce costs and increase physician well-being by reducing fatigue and making the work more meaningful. With medical imaging, for example, AI's capability in analysing images exceeds the human eye. AI algorithms based on deep learning models can detect anomalies easy for a human to miss. AI can therefore enhance doctors' ability to determine the results of tests for rectal cancer, lung disease and other illnesses. This elevates the standard of care, a clear win for patients. Similarly, where AI is used to enhance robotic-assisted surgeries , this means greater precision. If the ethics of data storage can be addressed, such applications should be relatively uncontroversial.
